Golidocitinib Combined With Selinexor for CAEBVD
Golidocitinib Combined With Selinexor for CAEBVD
Recruiting · NCT07369739 · Registry updated 2026-01-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Golidocitinib Combined With Selinexor for CAEBVD | CAEBV; EBV; Lymphohistiocytosis | Recruiting | Phase 2 / Phase 3 | 2026-01-27 | NCT07369739 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Friendship Hospital | 120 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Friendship Hospital | Beijing | China | 9 |